Introduction to Cardiovascular System Medications

The cardiovascular system is central to overall physiological function, and its disorders represent a significant global health burden. As future Bachelor of Science in Nursing (BSN) professionals, a robust understanding of medications affecting this system is paramount. This lecture delves into various categories of cardiac medications, their mechanisms, indications, adverse effects, contraindications, and crucial nursing considerations to ensure safe and effective patient care.

Understanding Cardiac Arrhythmias

Cardiac arrhythmias, commonly known as irregular heartbeats, occur when the electrical signals coordinating heart function do not work properly, leading to the heart pumping too fast (tachycardia) or too slow (bradycardia). Understanding the heart's electrical conduction system is key:

  • SA Node (Sinoatrial Node): Located in the right atrium, the SA node acts as the heart's natural pacemaker, generating electrical impulses that spread across the atria, causing them to contract.
  • AV Node (Atrioventricular Node): These impulses then pass to the AV node, which delays the signal slightly before transmitting it to the ventricles (lower chambers) via the Bundle of His and Purkinje fibers, causing ventricular contraction and blood ejection to the body.

Any disruption in this organized electrical pathway can lead to arrhythmias. Arrhythmias are broadly categorized by their origin:

  • Supraventricular Arrhythmias: Originate above the ventricles (in the atria or AV node).
  • Ventricular Arrhythmias: Originate within the ventricles.

Common types of arrhythmias include:

  • Tachycardia: Heart rate exceeding 100 beats per minute (bpm).
  • Bradycardia: Heart rate below 60 bpm.
  • Atrial Fibrillation (AFib): The most common type, characterized by chaotic, rapid electrical signals in the atria, causing them to quiver rather than beat effectively. This can lead to blood clot formation and stroke.
  • Atrial Flutter: Similar to AFib but with a more organized, rapid electrical activity in the atria, often leading to a 'sawtooth' pattern on ECG.
  • Supraventricular Tachycardia (SVT): A rapid heart rate originating from above the ventricles.
  • Ventricular Fibrillation (VFib): The most dangerous type, where ventricles quiver ineffectively, preventing proper blood pumping, leading to cardiac arrest.
  • Sinus Bradycardia: A slower than normal heart rate originating from a slowed SA node impulse generation.
  • Heart Block (Atrioventricular Block): A condition where electrical signals between the atria and ventricles are partially or completely blocked, causing delayed or absent ventricular contraction. First-degree heart block is the mildest form, characterized by delayed signal conduction from the atria to the ventricles.

Cardiac Arrest: A sudden cessation of effective blood circulation due to heart failure to contract effectively. It often results from conditions like ventricular fibrillation. In such emergencies, immediate cardiopulmonary resuscitation (CPR) is critical to restore blood supply and oxygen to vital organs, significantly improving survival rates. Early recognition and intervention are paramount for nurses.

Major Classes of Cardiovascular Medications

1. Beta Blockers (Beta-Adrenergic Receptor Blockers)

Beta blockers are a class of medications used for various indications, primarily to manage cardiac arrhythmias, prevent cardiac events post-myocardial infarction (MI), and treat hypertension. They act as beta-adrenergic receptor antagonists, diminishing the effects of endogenous catecholamines like adrenaline (epinephrine) and noradrenaline (norepinephrine).

Mechanism of Action

Beta blockers specifically block the action of these catecholamines on beta-adrenergic receptors, which are part of the sympathetic nervous system's 'fight or flight' response.

Types of Beta Receptors

  • Beta-1 Receptors: Primarily located in the heart and kidneys.
  • Beta-2 Receptors: Found mainly in the lungs, gastrointestinal tract, liver, uterus, vascular smooth muscle, and skeletal muscle.
  • Beta-3 Receptors: Located in fat cells.

Indications for Beta Blockers

  • Angina Pectoris
  • Myocardial Infarction (Post-MI)
  • Cardiac Arrhythmias (e.g., Atrial Fibrillation, Ventricular Tachycardia, Supraventricular Tachycardia)
  • Hypertension
  • Essential Tremors
  • Mitral Valve Prolapse
  • Symptomatic control of tachycardia and tremors in anxiety and hyperthyroidism.

Examples of Beta Blockers (Suffix: -lol)

  • Atenolol (Tenormin): 25, 50, 100 mg
  • Metoprolol (Lopressor, Toprol XL): 25-100 mg
  • Propranolol (Inderal): 10, 40 mg
  • Bisoprolol (Zebeta, Concor): 2.5, 5, 10 mg
  • Carvedilol (Coreg): 6.25, 12.5, 25 mg

Side Effects

  • Cold extremities
  • Bradycardia (slow heart rate)
  • Nervousness
  • Nausea
  • Weakness, Dizziness
  • Dry mouth, dry skin/eyes
  • Edema of hands and feet

Contraindications

  • Hypersensitivity
  • Severe Bradycardia
  • Cardiogenic Shock
  • First-degree Heart Block (caution, but often contraindicated if severe)
  • Asthma or Non-allergic Bronchospastic Disorders (due to potential Beta-2 blockade)
  • Impaired Renal Function (caution/dose adjustment needed)

Nursing Care

  • Monitor vital signs and ECG closely.
  • Teach patients to take their pulse before and after taking beta blockers.
  • Instruct patients to withhold the dose and notify the physician if pulse is below 60 bpm.
  • Advise patients to report any serious adverse effects immediately.
  • Teach patients to change positions slowly to prevent orthostatic hypotension.
  • Caution patients against abruptly discontinuing the drug without physician's order.

2. Calcium Channel Blockers (CCBs)

Calcium channel blockers are a class of medications that affect the heart and blood vessels by blocking the entry of calcium ions into the cells of the heart and arterial walls.

Mechanism of Action

Calcium plays a crucial role in muscle contraction. When calcium ions enter specialized L-type voltage-gated calcium channels in heart and blood vessel cells, it leads to vasoconstriction and stronger heart muscle contraction. CCBs block these channels, reducing calcium influx, which in turn relaxes blood vessels, decreases heart rate, and reduces contractility.

Types of Calcium Channel Blockers

  1. Dihydropyridines: Primarily act on blood vessels, causing vasodilation. They have less direct effect on heart conduction. Examples include:
    • Amlodipine (Norvasc)
    • Nifedipine (Procardia)
    • Isradipine (Dynacirc)
  2. Non-dihydropyridines: Have a more pronounced effect on the heart, slowing heart rate and decreasing contractility, in addition to causing vasodilation. They are also effective in controlling arrhythmias. Examples include:
    • Verapamil (Calan, Isoptin)
    • Diltiazem (Cardizem, Dilacor)

Pathophysiology

CCBs cause coronary artery dilation and peripheral arteriole dilation. This leads to decreased cardiac contractility (negative inotropic effect) and slows SA and AV node conduction, ultimately improving myocardial oxygen supply and reducing oxygen demand.

Indications for CCBs

  • Supraventricular Tachycardia (SVT)
  • Hypertension
  • Cerebrovascular Spasm
  • Reduction of cardiovascular hypertrophy
  • Reduction of atherosclerotic lesions
  • Myocardial protection from ischemic damage
  • Angina

Examples of CCBs

  • Diltiazem (Cardizem, Dilacor): 30-60 mg (oral), SR 90-180 mg
  • Verapamil (Calan, Isoptin): 40-280 mg (oral), SR 240 mg
  • Amlodipine (Norvasc): 5-10 mg

Side Effects

  • Fluid retention
  • Peripheral edema
  • Headache, dizziness
  • Flushing
  • Constipation (especially with verapamil)

Contraindications

  • Hypersensitivity
  • Lactating mothers
  • Renal impairment (caution/dose adjustment)
  • Cardiogenic shock
  • Second or third-degree AV block

Nursing Care

  • Administer drugs exactly as prescribed.
  • Teach patients to check their pulse before each dose and notify the physician if it's below 60 bpm or irregular.
  • Advise patients to limit salt intake, as these drugs can lead to fluid retention.
  • Monitor for signs of peripheral edema.

3. Alpha Blockers (Alpha-Adrenergic Blocking Agents)

Alpha blockers are a class of medications that block the action of norepinephrine (a stress hormone and neurotransmitter) on alpha-adrenergic receptors throughout the body.

Mechanism of Action

By binding to and blocking alpha-adrenergic receptors (primarily Alpha-1 receptors on vascular smooth muscle), alpha blockers interfere with the sympathetic nervous system's vasoconstrictive effects. This leads to relaxation of blood vessels and a decrease in blood pressure.

Indications for Alpha Blockers

  • Hypertension (to relax blood vessels and lower BP)
  • Benign Prostatic Hyperplasia (BPH) (relax smooth muscles in the prostate gland and bladder neck, easing urination difficulties)
  • Ophthalmic Hyperemia (some eye drops use alpha-adrenergic agonists to constrict conjunctival blood vessels, reducing redness; alpha blockers are distinct in their action for systemic conditions).

Examples of Alpha Blockers (Suffix: -osin)

  • Doxazosin (Cardura): 2-4 mg
  • Prazosin (Minipress): 1-2 mg
  • Terazosin (Hytrin): 1, 2, 5 mg

Side Effects

  • Dizziness, particularly orthostatic hypotension (due to vasodilation)
  • Nasal congestion (due to dilation of nasal mucosa)
  • Headache
  • Reflex tachycardia
  • May exacerbate MI, coronary insufficiency, angina, or heart failure in susceptible individuals.

Contraindications

  • Hypersensitivity
  • Caution in pregnant or breastfeeding women.

Nursing Care

  • Advise patients to remain in a sitting or lying position after taking the medication and avoid sudden standing to prevent dizziness and orthostatic hypotension.
  • Perform baseline assessments including vital signs, peripheral pulses, skin color, temperature, and capillary refill.
  • Advise patients to avoid alcohol or excessive exercise and prolonged standing, as these can intensify adverse effects.
  • Instruct patients to report dizziness or irregular heartbeats to their doctor.

4. ACE Inhibitors (Angiotensin-Converting Enzyme Inhibitors)

ACE inhibitors are a class of drugs that interfere with the body's Renin-Angiotensin-Aldosterone System (RAAS), a complex hormonal system that regulates blood pressure.

Mechanism of Action

ACE inhibitors specifically block the angiotensin-converting enzyme, which is responsible for converting angiotensin I to angiotensin II. Angiotensin II is a potent vasoconstrictor and also stimulates aldosterone secretion. By inhibiting its formation, ACE inhibitors lead to:

  • Vasodilation (reduced peripheral arterial resistance)
  • Decreased aldosterone secretion, which reduces sodium and water retention in the body.

Indications for ACE Inhibitors

  • Hypertension
  • Heart Failure
  • Diabetic Nephropathy (protects kidneys)
  • Liver Dysfunction (caution required)

Examples of ACE Inhibitors (Suffix: -pril)

  • Captopril (Capoten): 25 mg
  • Enalapril (Vasotec): 5-10 mg
  • Lisinopril (Zestril, Prinivil): 5, 10, 20 mg

Side Effects

  • Dry mouth
  • Persistent dry cough (common)
  • Fatigue, dizziness
  • Hyperkalemia
  • Angioedema (rare but serious)

Contraindications

  • Hypersensitivity to ACE inhibitors.
  • Pregnancy (known teratogen).
  • History of angioedema.
  • Use with caution in patients with renal function problems or serious autoimmune diseases.

Nursing Care

  • Caution patients to avoid sudden position changes to minimize orthostatic hypotension.
  • Inform patients about potential dry mouth and cough.
  • Warn patients against taking self-prescribed cold preparations without medical approval, as some may contain vasoconstrictors.
  • Monitor renal function and potassium levels.

5. ARBs (Angiotensin II Receptor Blockers)

ARBs are a class of medications that also target the RAAS but at a different point than ACE inhibitors.

Mechanism of Action

ARBs block the action of angiotensin II by preventing it from binding to its specific receptors (Angiotensin II Type 1 receptors) on blood vessels and other tissues. This leads to:

  • Vasodilation and a reduction in blood pressure.
  • Decreased aldosterone release, promoting sodium and water excretion, further lowering blood volume and pressure.

They are often used as an alternative for patients who develop the persistent cough associated with ACE inhibitors.

Indications for ARBs

  • High Blood Pressure (Hypertension)
  • Heart Failure
  • Atrial Fibrillation
  • Nephropathy in Type 2 Diabetes

Examples of ARBs (Suffix: -sartan)

  • Losartan (Cozaar): 25, 50 mg
  • Irbesartan (Avapro): 100 mg
  • Valsartan (Diovan): 80 mg
  • Telmisartan (Micardis): 20, 40, 80 mg

Side Effects

  • Dizziness, lightheadedness
  • Fatigue
  • Diarrhea
  • Hyperkalemia

Contraindications

  • Hypersensitivity (especially if sensitive to ACE inhibitors, though cough is less common).
  • Pregnancy.
  • Severe renal or hepatic dysfunction (use with caution).

Nursing Care

  • Instruct patients to take the prescribed drug exactly as ordered.
  • Warn patients not to stop the drug abruptly.
  • Advise patients to avoid sudden changes in position to prevent dizziness and fainting.
  • Caution patients against physical exertion, especially in hot weather, as it can exacerbate adverse effects.
  • Monitor blood pressure and kidney function.

6. Diuretics

Diuretics are drugs that increase the rate of urination and promote forced diuresis, leading to increased excretion of water from the body. They are categorized based on their site of action within the nephron.

Mechanism of Action

All diuretics ultimately increase the excretion of water by affecting sodium and water reabsorption in different parts of the renal tubules. Water naturally follows sodium, so by preventing sodium reabsorption, diuretics increase water excretion.

Types of Diuretics

  1. Loop Diuretics: (e.g., Furosemide/Lasix, Bumetanide/Bumex, Torsemide/Demadex)
    • Mechanism: Inhibit the sodium-potassium-chloride cotransporter in the thick ascending limb of the loop of Henle, preventing sodium, potassium, and chloride reabsorption, leading to significant water loss.
    • Uses: Edema (pulmonary, peripheral), hypertension.
    • Side Effects: Dehydration, electrolyte imbalance (hypokalemia, hyponatremia), increased urination.
  2. Thiazide Diuretics: (e.g., Hydrochlorothiazide/Hydrodiuril, Chlorthalidone, Indapamide)
    • Mechanism: Act on the distal convoluted tubule, inhibiting sodium and chloride reabsorption.
    • Uses: Hypertension (first-line for many), edema.
    • Side Effects: Increased urination, electrolyte imbalance (hypokalemia, hyponatremia, hypercalcemia), dehydration.
  3. Potassium-Sparing Diuretics: (e.g., Spironolactone/Aldactone, Amiloride, Triamterene/Dyrenium)
    • Mechanism:
      • Spironolactone: Blocks aldosterone receptors in the collecting tubule, preventing sodium reabsorption and potassium excretion.
      • Amiloride/Triamterene: Directly block sodium channels in the collecting tubule, reducing sodium-potassium exchange.
    • Uses: Edema, hypertension, prevention of hypokalemia (often used with loop/thiazide diuretics).
    • Side Effects: Hyperkalemia (major concern), gynecomastia (with spironolactone).
  4. Osmotic Diuretics: (e.g., Mannitol)
    • Mechanism: Compounds that are filtered at the glomerulus but not reabsorbed, increasing the osmolarity of the filtrate. This draws water from the body into the renal tubules, promoting water excretion.
    • Uses: Cerebral edema (to reduce intracranial pressure), acute glaucoma (to reduce intraocular pressure).
    • Side Effects: Dehydration, hypotension, electrolyte imbalances.

Clinical Uses

  • Treat or prevent acute renal failure
  • Congestive Heart Failure (CHF)
  • Ascites
  • Nephrotic Syndrome
  • Reduce intraocular pressure in glaucoma

Examples of Diuretics

  • Furosemide (Lasix): 20, 40, 80 mg (oral), injection
  • Spironolactone (Aldactone): 25, 50, 100 mg (oral)
  • Mannitol: 500 mL IV solution (various concentrations)
  • Hydrochlorothiazide (Microzide): 12.5, 25, 50 mg (oral)

Side Effects & Contraindications

  • Contraindicated: Anuria (absence of urine), hypersensitivity, severe hypovolemia, severe hypokalemia, hyponatremia, metabolic alkalosis.
  • Loop Diuretic Specific Side Effects (Lasix toxicity): Fever, vertigo, headache, weakness, gout, seizures, tinnitus (ringing in the ears).

Nursing Care

  • Monitor patient's weight, peripheral edema, breath sounds, blood pressure, I/O chart, and serum electrolytes.
  • Advise patients to stand slowly to prevent dizziness.
  • Instruct patients to report ringing in the ears (tinnitus), severe abdominal pain, or fever, as these may indicate Lasix toxicity.
  • Educate patients on potassium-rich foods or potassium supplementation, depending on the diuretic type.

7. Chronotropic, Inotropic, and Dromotropic Effects

These terms describe the effects of drugs on specific aspects of heart function:

  • Chronotropic Effect: Refers to changes in heart rate.
    • Positive Chronotropic: Increases heart rate (e.g., adrenaline, atropine).
    • Negative Chronotropic: Decreases heart rate (e.g., beta blockers, calcium channel blockers, adenosine).
  • Inotropic Effect: Refers to changes in myocardial contractility (force of contraction).
    • Positive Inotropic: Increases contractility (e.g., dopamine, adrenaline, dobutamine, digoxin).
    • Negative Inotropic: Decreases contractility (e.g., beta blockers, calcium channel blockers).
  • Dromotropic Effect: Refers to changes in the conduction velocity of electrical impulses, particularly through the AV node.
    • Positive Dromotropic: Increases conduction velocity (e.g., dopamine).
    • Negative Dromotropic: Decreases conduction velocity (e.g., digoxin, calcium channel blockers).

8. Inotropic Drugs

Inotropic drugs are medications that alter the force or energy of muscular contractions. Clinically, they are used to improve cardiac contractility.

Types of Inotropes

  1. Cardiac Glycosides: (e.g., Digoxin)
    • Mechanism: Direct effect on cardiac muscle and conduction system; indirect effect via autonomic nervous system modulation. They increase myocardial contractility (positive inotropic effect), decrease heart rate (negative chronotropic effect), and decrease AV node conduction velocity (negative dromotropic effect).
    • Digoxin Administration: Can be given intravenously (IV) or orally. IV injections should be administered slowly over 15 minutes. Oral absorption is slower but typically effective. Intramuscular administration is not recommended due to unpredictable absorption and local pain.
    • Digoxin Loading Dose: Typically 0.5 mg initially, followed by 0.25 mg every 6-8 hours for two doses, totaling 1 mg/day. It is diluted in 0.9% Sodium Chloride, 5% Dextrose in Water, or sterile water.
    • Digoxin Maintenance Dose: Usually starts at 0.125 to 0.375 mg per day.
  2. Sympathomimetics: (e.g., Epinephrine, Dopamine, Dobutamine, Norepinephrine, Isoproterenol)
    • Mechanism: Stimulate beta-1, beta-2, alpha-1, and dopaminergic receptors in the myocardium, blood vessels, and sympathetic nervous system.
    • Dopamine: A chemical precursor to norepinephrine. Its specific effects are dose-dependent:
      • Low Dose (Renal Dose, 0.5-2 mcg/kg/min): Primarily dopaminergic effects, causing vasodilation of renal and mesenteric arteries, increasing blood flow and GFR, useful in patients resistant to diuretics, increasing urine output.
      • Intermediate Dose (2-10 mcg/kg/min): Primarily beta-adrenergic activity, causing a modest increase in systemic vascular resistance (SVR), cardiac output (CO), and central venous pressure (CVP).
    • Warnings for Sympathomimetics: Correct hypovolemia prior to administration. Do not infuse peripherally; extravasation can cause severe tissue necrosis. Carefully monitor circulation in extremities.
    • Adverse Effects: Tachycardia, supraventricular tachycardia, ventricular arrhythmias, pulmonary congestion, nausea, vomiting, headache, increased myocardial oxygen demand.
  3. Phosphodiesterase Inhibitors: (e.g., Milrinone/Primacor, Enoximone/Inocor)
    • Mechanism: Increase intracellular cAMP, leading to increased calcium availability and enhanced myocardial contractility and vasodilation.

9. Antiarrhythmic Drugs

Antiarrhythmic drugs are specifically designed to prevent and treat abnormal heart rhythms (arrhythmias).

Mechanism of Action

These agents work by modulating the heart's electrical activity, often by affecting ion channels (e.g., sodium, potassium, calcium) that govern the action potential in cardiac cells. Many suppress the inward calcium current or affect calcium-dependent action potentials.

Indications for Antiarrhythmics

  • Atrial Fibrillation
  • Ventricular Tachycardia
  • Other specified arrhythmias

Examples of Antiarrhythmics

  • Amiodarone (Cordarone): 100, 200 mg (oral), 150 mg/3 mL (IV)
  • Lidocaine (Xylocaine): 1-2 g (IV), often used for ventricular arrhythmias.
  • Quinidine (Quinaglute, Quinidex): 200-300 mg (oral)

Side Effects & Contraindications

  • Contraindicated: Hypersensitivity, cardiogenic shock, second or third-degree heart block (unless a pacemaker is present).
  • Many antiarrhythmics have proarrhythmic effects, meaning they can worsen or cause new arrhythmias.
  • Amiodarone has numerous side effects, including pulmonary fibrosis, thyroid dysfunction, and corneal deposits.

Nursing Care

  • Administer drugs exactly as prescribed.
  • Teach patients to take their pulse before and after each dose; notify the physician if irregular or below 60 bpm.
  • Instruct patients to avoid hazardous activities if experiencing dizziness or fatigue.
  • Advise limited fluid and salt intake if fluid retention is a concern.
  • Monitor ECG for rhythm changes and QT prolongation.

10. Nitrates

Nitrates are potent vasodilators primarily used to treat angina pectoris and other cardiovascular conditions.

Mechanism of Action

Nitrates relax smooth muscles in blood vessels, leading to vasodilation. They have a prominent effect on peripheral veins, causing venous pooling, which reduces venous return to the heart (preload). This reduction in preload decreases cardiac oxygen demand. They also dilate coronary arteries, improving blood flow to ischemic regions of the myocardium.

Clinical Uses

  • Angina Prophylaxis and Treatment
  • Congestive Heart Failure (CHF)
  • Hypertension related to surgery or hypertensive crisis

Examples of Nitrates

  • Isosorbide Mononitrate (Imdur, Ismo, Monoket): 20-40 mg (oral), XR 60 mg
  • Isosorbide Dinitrate (Isordil, Dilatrate): 5, 10, 20 mg (oral)
  • Nitroglycerin (Nitrostat, Nitro-Dur, Sustac): Sublingual tablets (0.3, 0.4, 0.6 mg), transdermal patch, IV infusion.

Side Effects (Most Common)

  • Headache
  • Flushing
  • Dizziness
  • Orthostatic hypotension
  • Reflex tachycardia

Contraindications

  • Hypersensitivity
  • Hypertrophic Obstructive Cardiomyopathy
  • Aortic Stenosis
  • Constrictive Pericarditis
  • Closed-Angle Glaucoma
  • Use with phosphodiesterase-5 inhibitors (e.g., sildenafil) due to severe hypotensive risk.

Nursing Care

  • Monitor vital signs hourly, especially blood pressure, and assess effectiveness of the dose.
  • Observe for adverse reactions.
  • Warn patients not to discontinue the drug abruptly.
  • Advise patients not to stand up quickly after taking the medicine.
  • Instruct patients to go to the emergency room if angina pain is not relieved after taking tablets 5 minutes apart (e.g., for sublingual nitroglycerin).

11. Vasodilators

Vasodilators are drugs that relax vascular smooth muscles, leading to the dilation of blood vessels.

Mechanism of Action

Vasodilators directly relax the smooth muscle cells within the walls of blood vessels, increasing vessel lumen diameter. They are broadly classified by their primary site of action:

  • Venous Dilators: Predominantly dilate veins, reducing venous pressure and decreasing preload to the heart. This reduces cardiac oxygen demand and is useful in angina.
  • Arterial Dilators: Primarily dilate arterioles, reducing arterial pressure and systemic vascular resistance (SVR). This reduces afterload, making it easier for the heart to pump blood, benefiting patients with hypertension and heart failure.

Clinical Uses

  • Hypertension
  • Heart Failure
  • Pulmonary Hypertension
  • Angina

Examples of Vasodilators

  • Hydralazine (Apresoline): 25 mg (oral), IV
  • Minoxidil (Loniten): Oral
  • Nitroprusside (Nitropress): IV (potent vasodilator for hypertensive crises)

Side Effects & Contraindications

  • Contraindicated: Hypersensitivity, severe hypotension.
  • Caution: In patients with liver or kidney insufficiency.
  • Side Effects: Headache, dizziness, nausea, reflex tachycardia, fluid retention, lupus-like syndrome (with hydralazine).

Nursing Care

  • Monitor vital signs regularly, especially blood pressure.
  • Administer the prescribed dose exactly as ordered.
  • Monitor for any adverse reactions.
  • Advise patients to avoid sudden standing to prevent orthostatic hypotension and dizziness.

12. Antiplatelet Drugs

Antiplatelet drugs impede clotting by blocking platelet aggregation and synthesis of substances like thromboxane, preventing the formation of blood clots.

Mechanism of Action

Platelets are tiny blood cells crucial for forming blood clots to stop bleeding after injury. Antiplatelet drugs prevent platelets from sticking together and forming inappropriate clots within blood vessels. For example, aspirin inhibits cyclooxygenase (COX-1), reducing thromboxane A2 production, a potent platelet aggregator.

Clinical Uses

  • Prevention of Heart Attack and Stroke
  • Acute Coronary Syndrome (ACS)
  • Peripheral Artery Disease (PAD)
  • Atrial Fibrillation (when anticoagulants are contraindicated or used in combination)

Examples of Antiplatelet Drugs

  • Aspirin (Ecotrin, Bayer): 75-150 mg (often 'baby aspirin' 81mg for prophylaxis)
  • Clopidogrel (Plavix): 75 mg
  • Dipyridamole (Persantine): 25-100 mg

Side Effects

  • Bleeding (major concern, e.g., GI bleeding, bruising)
  • Headache
  • Dizziness
  • Gastrointestinal upset (nausea, heartburn)

Nursing Care

  • Be alert for adverse reactions such as headache, bleeding (e.g., melena, hematuria), and dizziness.
  • Instruct patients to take oral antiplatelets with food, milk, antacids, or a large glass of water to reduce GI irritation.
  • Hold the dose and notify the doctor if signs of bleeding or severe adverse reactions develop.
  • Advise patients to avoid alcohol consumption, which can increase bleeding risk.
  • Encourage the use of a soft toothbrush and electric razor to minimize bleeding risk.

13. Anticoagulant Drugs

Anticoagulants are medications that prevent blood coagulation (clotting) or reduce the ability of blood to form clots.

Mechanism of Action

Unlike antiplatelets, anticoagulants primarily target specific blood clotting factors (proteins) in the coagulation cascade. They do not dissolve existing clots but prevent new ones from forming or existing ones from growing larger.

Clinical Uses

  • Deep Vein Thrombosis (DVT)
  • Pulmonary Embolism (PE)
  • Myocardial Infarction (MI)
  • Stroke (ischemic)
  • Congestive Heart Failure (CHF) with increased risk of clot formation
  • Atrial Fibrillation (to prevent cardioembolic stroke)

Examples of Anticoagulants

  • Warfarin (Coumadin): Dosed according to International Normalized Ratio (INR) target.
    • Antidote: Vitamin K
  • Heparin Sodium: Typically 25,000 units/5 mL (IV or SC).
    • Antidote: Protamine Sulfate
  • Novel Oral Anticoagulants (NOACs)/Direct Oral Anticoagulants (DOACs): (e.g., Dabigatran, Rivaroxaban, Apixaban, Edoxaban) - specific antidotes are becoming available for some.

Side Effects

  • Bleeding (major and most common risk)
  • Thrombocytopenia (Heparin-Induced Thrombocytopenia - HIT)
  • Bruising

Contraindications

  • Active bleeding
  • Recent surgery (especially neurosurgery or ophthalmic surgery)
  • Severe uncontrolled hypertension
  • Severe liver disease
  • Hypersensitivity

Nursing Care

  • Assess the patient's underlying condition and obtain baseline blood coagulation values (PT/INR for warfarin, PTT/aPTT for heparin) before initiating therapy.
  • For heparin infusion, monitor PTT or aPTT every 6 hours during intermittent IV therapy. Always draw blood 30 minutes before the next scheduled dose.
  • For patients on warfarin, monitor INR regularly to ensure therapeutic levels.
  • Educate the patient and family about the drug, its purpose, dosage, and precautions.
  • Emphasize the importance of reporting any signs of bleeding immediately.
  • Advise patients to avoid activities that increase the risk of injury and bleeding.

14. Lipid-Lowering Agents (Statins)

Statins are a class of lipid-lowering agents primarily used to reduce high levels of cholesterol and other fats (lipids) in the blood.

Mechanism of Action

Statins inhibit HMG-CoA reductase, an enzyme crucial for cholesterol synthesis in the liver. By blocking this enzyme, statins reduce the amount of cholesterol circulating in the blood, particularly low-density lipoprotein (LDL) cholesterol, often referred to as 'bad cholesterol'.

Indications for Statins

  • Hypercholesterolemia (high cholesterol)
  • Atherosclerosis
  • Coronary Artery Disease (CAD) prevention
  • Myocardial Infarction (MI) prevention (primary and secondary)

Examples of Statins

  • Simvastatin (Zocor): 10-20 mg
  • Rosuvastatin (Crestor): 5, 10, 20 mg
  • Ezetimibe (Zetia): 10 mg (often used in combination with statins)
  • Atorvastatin (Lipitor): 10-20 mg

Side Effects

  • Muscle pain (myalgia), tenderness, or weakness (rhabdomyolysis is a rare but serious complication)
  • Liver damage (elevated liver enzymes)
  • Headache
  • Insomnia
  • Mental confusion
  • Tingling or loss of sensation (paresthesia)
  • Can increase blood sugar/glucose levels in patients with Type 2 Diabetes.
  • Rashes, dizziness, fatigue, GI upset (abdominal cramps, flatulence)
  • Memory loss, drowsiness.

Contraindications

  • Pregnancy
  • Breastfeeding women
  • Active liver disease (e.g., hepatitis)
  • Hypersensitivity

Nursing Care

  • Obtain a complete health history, including any allergic problems, and assess for a history of liver or muscle disease.
  • Perform baseline liver function tests (LFTs) and lipid studies. A pregnancy test is essential for women of childbearing age.
  • Monitor for concurrent alcohol use, as alcohol can negatively affect liver function.
  • Monitor blood cholesterol and triglyceride levels at regular intervals during therapy.
  • Monitor Creatine Phosphokinase (CPK) enzyme levels if the patient reports muscle tenderness or weakness, to rule out rhabdomyolysis.
  • Instruct patients to adhere to a low-saturated fat, low-cholesterol diet.